Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country entities : Soligenix, inc. save search
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 75.34%
H: 37.73%
C: -30.58%
fda drug marburg infection designation for grants
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 3.67%
H: 0.46%
C: -19.02%
fda drug infection designation for grants
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Published: 2024-03-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 0.5%
H: 7.98%
C: -3.13%
year financial results
Soligenix Announces Appointment of Timothy R. Coté, M.D. to its Board of Directors
Published: 2023-05-03 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 1.24%
H: 3.4%
C: -12.35%
Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Published: 2022-11-15 (Crawled : 13:20) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 0.0%
H: 2.66%
C: -6.8%
transfer program technology funding
Soligenix Announces Adjournment of Annual Meeting and Information for Reconvened Meeting
Published: 2022-10-20 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 2.81%
H: 0.0%
C: -1.48%
meeting
Soligenix to Present at the H.C. Wainwright Global Investment Conference
Published: 2022-05-18 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 3.25%
H: 10.64%
C: -5.89%
conference
Soligenix Receives $1.4M in Non-Dilutive Government Funding
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 0.47%
H: 0.04%
C: -1.22%
funding
Soligenix to Present at the Q1 Virtual Investor Summit
Published: 2022-03-02 (Crawled : 13:30) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: -0.25%
H: 4.82%
C: -2.63%
Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 12.47%
H: 17.77%
C: -5.81%
positive
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published: 2021-12-02 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: -4.6%
H: 1.22%
C: -6.0%
vaccine
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 12.38%
H: 4.24%
C: -1.69%
treatment fda drug t-cell granted grant designation
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Published: 2021-08-23 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 7.22%
H: 1.4%
C: 0.49%
disease vaccine marburg
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Published: 2021-08-18 (Crawled : 14:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 15.94%
H: 6.73%
C: -7.79%
positive vaccine preclinical pre-clinical
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
Published: 2021-08-13 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
financial results results
HyBryte™ Expanded Efficacy and Safety Data Presented at the American Academy of Dermatology Meeting
Published: 2021-04-26 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 1.41%
H: 9.72%
C: 9.72%
Soligenix Announces Presentations at Prominent Scientific Conferences
Published: 2021-04-13 (Crawled : 12:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 1.4%
H: 0.69%
C: -0.69%
presentation conference
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
Published: 2021-02-11 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 6.55%
H: 12.3%
C: 11.23%
ceo leo
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
Published: 2021-01-07 (Crawled : 19:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 9.92%
H: 5.56%
C: -0.69%
partnership distribution t-cell treatment
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
Published: 2020-12-08 (Crawled : 16:01) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 5.08%
H: 0.0%
C: -6.85%
vaccine
Gainers vs Losers
| 63% | 37% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
ASNS | $0.828 21.75% 17.86% 18K
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.